Drugs with this side effect
- Abarelix: 9.88%
- BPTI
- Bivalirudin: 4.12% - 4.56%
- Buscopan
- Cantril
- Goserelin: 0% - 1.27%
- Histrelin
- L-Dmp: infrequent
- Leuprorelin
- Mersyndol
- PGE2
- Photofrin II: uncommon
- Revasc
- Stalevo 50
- Supremon
- Triptorelin: 0% - 5%
- Zyprexa Relprevv
- acetaminophen: postmarketing
- aclidinium bromide
- alprazolam
- alvimopan
- amantadine: rare
- amitriptyline
- amoxapine
- amphotericin B
- aripiprazole
- atomoxetine: postmarketing, 3% - 8%
- atorvastatin
- atropine
- azelastine: postmarketing
- baclofen: rare, common, 0.7% - 8%
- benztropine
- bexarotene
- bicalutamide
- bortezomib
- bromocriptine
- bupivacaine
- buprenorphine
- bupropion: postmarketing, 1.9%
- buspirone: postmarketing
- cabazitaxel
- capecitabine
- carbamazepine: very rare
- carbidopa
- carbinoxamine
- cetirizine: postmarketing
- cevimeline
- chlorpheniramine
- chlorpromazine
- cidofovir
- cimetidine
- ciprofloxacin: postmarketing
- citalopram: postmarketing, infrequent, uncommon
- clemastine
- clomipramine: very rare, 2% - 7%
- clonazepam
- clonidine
- clozapine: 1%
- codeine
- copolymer 1
- cyclizine
- cyclobenzaprine
- cyclopentolate
- cyproheptadine
- cytarabine: 0% - 10.7%
- dalteparin
- dantrolene
- darifenacin: uncommon
- delamanid
- deprenyl: 1%
- desipramine
- desvenlafaxine
- dextrorphan
- diazepam
- dicyclomine: postmarketing
- dihydrocodeine: uncommon
- diphenhydramine
- disopyramide: 7-13%
- dolasetron: 1.95%
- donepezil: infrequent
- dothiepin
- doxapram
- doxazosin: 1% - 1.6%
- doxepin
- duloxetine: postmarketing, rare, infrequent, uncommon
- ephedrine
- ertapenem
- esmolol: 1%
- everolimus
- felbamate
- fentanyl: very rare, postmarketing, 0% - 3%
- fesoterodine: 1.1% - 1.4%
- flecainide
- fluoxetine: infrequent
- fluvoxamine: postmarketing, rare, 1%
- fondaparinux: 2.9% - 2.96%
- foscarnet
- fosphenytoin: infrequent
- gabapentin: infrequent
- galantamine: infrequent
- glycine
- glycopyrrolate: uncommon, 15%
- haloperidol: very rare, postmarketing
- homatropine
- hydralazine: very rare
- hydrocodone
- hydromorphone
- ibandronate
- ibuprofen: 3.29% - 5.22%
- iloperidone
- imipramine: very rare
- imiquimod: postmarketing
- iopamidol
- iopromide
- ioversol
- ipratropium bromide: postmarketing, uncommon, 1.4%
- isocarboxazid: postmarketing
- ketorolac
- ketorolac tromethamine: postmarketing
- labetalol
- lamotrigine: rare, infrequent
- lansoprazole: postmarketing
- lenalidomide: postmarketing
- leuprorelin acetate
- levodopa/carbidopa
- levomepromazine
- lidocaine
- lomefloxacin: postmarketing
- loperamide: postmarketing
- loxapine
- mannitol
- maprotiline
- mecamylamine
- medroxyprogesterone acetate
- meloxicam
- memantine: postmarketing, infrequent
- meperidine
- mepivacaine
- methadone
- midodrine: common, 6%
- milnacipran
- mirabegron: postmarketing
- mirtazapine: postmarketing, infrequent
- modafinil
- molindone
- morphine
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- nabilone
- nalmefene
- naproxen
- nefazodone
- nefopam
- niacin
- nortriptyline
- ofloxacin
- olanzapine: very rare, infrequent
- ondansetron: 3.11% - 5.09%
- oxybutynin: uncommon, 1.2% - 6%
- oxycodone
- oxymorphone
- paliperidone: very rare, postmarketing
- palonosetron
- paroxetine: postmarketing, infrequent, uncommon
- pegaptanib
- pegaptanib sodium
- pentazocine
- pergolide: infrequent
- perindopril
- perindopril erbumine
- perphenazine
- phenelzine
- phenylpropanolamine
- phenytoin: infrequent
- pimozide: postmarketing
- pomalidomide
- pramipexole
- pregabalin: postmarketing, infrequent
- prochlorperazine
- promethazine
- propafenone
- propofol
- protriptyline
- quetiapine: postmarketing, infrequent
- ranolazine: postmarketing
- rapamycin
- rasagiline: infrequent
- reboxetine: 2.56%
- remifentanil: 0% - 1.7%
- retigabine
- riluzole: infrequent, uncommon
- risperidone: postmarketing, rare, infrequent
- ritonavir
- rivastigmine: infrequent
- rofecoxib
- ropinirole: infrequent
- ropivacaine: 0.9% - 4.83%
- scopolamine
- sertraline: postmarketing, rare, infrequent, common
- sevoflurane
- sibutramine
- solifenacin: 0% - 1.4%
- sparfloxacin: postmarketing
- sufentanil
- tacrolimus
- testosterone: postmarketing
- testosterone undecanoate
- theophylline
- thiotepa: 1-10%
- tiagabine: infrequent
- tiotropium
- tizanidine: infrequent
- tolcapone: infrequent
- tolterodine
- topiramate: infrequent
- tramadol: postmarketing, rare, uncommon
- tranylcypromine
- trazodone: postmarketing
- triazolam
- trifluoperazine
- trimipramine
- trospium chloride: 1.18%
- umeclidinium
- valrubicin
- varenicline: rare
- venlafaxine: infrequent, uncommon
- vincristine
- voriconazole
- zalcitabine
- zaleplon: rare
- ziconotide: 9%
- ziprasidone: infrequent
- zolpidem: rare
- zonisamide: infrequent
- zuclopenthixol
|
Drugs with this indication
|
